Helping our clients make a meaningful impact on patients’ lives through New Science, novel medical technologies and better collaboration.
Pfizer’s vaccine rollout strategy
Making patient-centric supply chains the norm
A new economic environment is demanding change in biopharma. Rising costs of New Science and patient care coupled with a slow embrace of technology has the industry at an inflection point where companies must do the impossible:
Produce and deliver more effective, affordable, personalized treatments—all while adapting to new ways of working at crisis pace.
All the while, technology giants are looking to replace industry incumbents. Add in a growing health equity gap accelerated by social injustice and mid-pandemic uncertainty – biopharma companies need new solutions to navigate all of this.
The answer? Novel technology—the same technology used by those giants looking to breakthrough—coupled with New Science, human ingenuity and an unwavering commitment to improving patient outcomes.
Our 2021 survey revealed that leaders don’t wait for the “new normal,” they build it themselves. These five trends help forge a better future.
Our US survey of 1,755 people focuses on four themes that explore key aspects of health experiences today: Technology, Experience, Access and Trust.
America’s Best Management Consulting Firms 2021
Accenture | 5 stars from Forbes in life sciences.
Accenture Life Sciences offers a full range of services in Strategy, Consulting, Accenture Interactive, Operations and Technology that help deliver more personalized healthcare and better patient outcomes.
Driving digital in biopharma [podcast series]
Experts discuss biopharma’s digital transformation
We help our clients make a meaningful impact on patients’ lives by combining new science and human ingenuity with leading-edge technology. Our life sciences consulting services are powered by deep industry experience and backed by a global presence.
20K+
Life sciences professionals in 50+ countries.
10OUT OF10
Deep expertise in all 10 of the top 10 therapeutic areas.
90%
Helping 90% of Fortune 500 life sciences companies deliver improved outcomes for more than two decades.
A patient-centric supply chain requires that biopharma companies go beyond digitizing their supply chain and put patients at the center of operations.
The future health experience should be more impactful, meaningful and inclusive. We identify five opportunities to redefine the health experience.
New Science has the potential to make medicine vastly more precise and effective, but will its price tag keep it out of most people’s reach?
How Accenture helped a pharma giant unlocked greater value and performance by standardizing and harmonizing processes globally.
Public-private partnership model transforms primary care for Kenya’s citizens.
Bristol Myers Squibb upgrades global SAP to S/4HANA in the AWS cloud flawlessly and without business disruption.
Life Sciences consultants weigh in on how pharma, biotech, medtech and consumer health companies can improve patient outcomes.
Biopharma leadership is entering a prime time for dramatic change to the R&D landscape.
Accenture describes three ways to transform the economic relationship with biopharma customers.
Accenture explores how changes in personalized, complex medicines are challenging health systems’ ability to afford the care that populations require.
Our Life Sciences solutions are helping businesses deliver exceptional patient experiences. Discover how our awards distinguish us as an industry leader.
EVEREST GROUP PEAK SERVICES MATRIX
HFS RESEARCH
AMERICA’S BEST MANAGEMENT CONSULTING FIRMS
EVEREST GROUP PEAK MATRIX REPORT
EVEREST GROUP PEAK MATRIX REPORT
MICROSOFT
Accenture is named a leader for its market impact, vision, and capabilities in the Everest Group’s Veeva PEAK Services Matrix® Assessment 2021 report.
Medable was named Accenture HealthTech Innovation Challenge – Life Sciences Innovation Champion, providing an integrated clinical trial patient experience.
Collaboration will leverage cloud and data-driven insights to accelerate drug development, increase operational agility, reduce technology costs and develop the workforce of the future.
filter result
Managing Director – Asia Pacific Life Sciences Lead
Managing Director – Life Sciences, Global Supply Chain and Industry X
Managing Director – Accenture Strategy, Commercial, Sales and Marketing, Life Sciences
